Skip to main content
Funded Studies

Dag Aarsland, MD, PhD

Professor and Head of Department of Old Age Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience at King’s College London

Location: London United Kingdom

Dag Aarsland, MD, PhD, conducts research on a wide variety of topics within psychiatry and neuropsychiatry of older adults, with a focus on neuropsychiatric problems in people with Parkinson’s disease (PD) and Dementia with Lewy bodies. He has been actively involved in the international task forces developing diagnostic criteria for dementia and mild cognitive impairment in PD and Dementia with Lewy bodies. He played a central role in the study and subsequent paper that led to the licensing of rivastigmine for parkinsonian dementia. His current research centers on biomarker development. As the chair of the steering committee of The European-Dementia of Lewy Body Consortium, Professor Aarsland oversees groundbreaking initiatives. With more than 600 scientific papers, numerous books and extensive conference participation, his contributions significantly impact the fields of psychiatry and neurology.

Associated Grants

  • Assessment of the Novel Neuronal Synuclein Disease Staging System in Stratifying Dementia with Lewy Bodies Patients


  • Parkinson’s Disease with Mild Cognitive Impairment Treated with a Nicotinic Agonist Drug


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.